GSK Seeks To Strike Fraud Claims In Zofran MDL

By Emily Field (May 8, 2017, 5:37 PM EDT) -- GlaxoSmithKline PLC on Monday asked a Massachusetts federal court to strike fraud-based claims about its marketing of anti-nausea drug Zofran from multidistrict litigation alleging that the drug is linked to birth defects, saying that it will be prejudiced if consumers are allowed to obtain discovery on those claims....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!